Chia‐Ming Chu, Yun‐Fan Liaw – 26 April 2007 – Spontaneous hepatitis B surface antigen (HBsAg) seroclearance in chronic HBV infection has long been suggested as a rare event in high endemic areas. The prevalence of HBsAg in the general population of Taiwan, however, decreased remarkably from 15%‐20% before age 40 to 5%‐10% after age 60 or 70. This study aimed to reexamine the rates of HBsAg seroclearance by a long‐term follow‐up of 1965 hepatitis B e antibody–positive asymptomatic adult carriers.

David H. Perlmutter, Jeffrey L. Brodsky, William F. Balistreri, Bruce C. Trapnell – 26 April 2007 – In recent years, we have witnessed several important paradigm shifts in understanding the molecular basis of liver disease in alpha‐1‐antitrypsin (AT) deficiency. These shifts have become possible as a result of a number of advances in research on the cell biology of aggregation‐prone mutant proteins and in research on the pathobiological mechanisms of liver disease in general.

Heiner Wedemeyer, Benjamin Heidrich, Michael P. Manns – 26 April 2007

Byung Chul Yoo, Ju Hyun Kim, Young‐Hwa Chung, Kwan Sik Lee, Seung Woon Paik, Soo Hyung Ryu, Byung Hoon Han, Joon‐Yeol Han, Kwan Soo Byun, Mong Cho, Heon‐Ju Lee, Tae‐Hun Kim, Se‐Hyun Cho, Joong‐Won Park, Soon‐Ho Um, Seong Gyu Hwang, Young Soo Kim, Youn‐Jae Lee, Chae Yoon Chon, Byung‐Ik Kim, Young‐Suk Lee, Jin‐Mo Yang, Haak Cheoul Kim, Jae Seok Hwang, Sung‐Kyu Choi, Young‐Oh Kweon, Sook‐Hyang Jeong, Myung‐Seok Lee, Jong‐Young Choi, Dae‐Ghon Kim, Yun Soo Kim, Heon Young Lee, Kwon Yoo, Hee‐Won Yoo, Hyo‐Suk Lee – 26 April 2007 – Clevudine is a pyrimidine analogue with potent and sustained antivi

Fabrizio Parente, Luca Pastore, Stefano Bargiggia, Claudia Cucino, Salvatore Greco, Mirko Molteni, Sandro Ardizzone, Gabriele Bianchi Porro, Gianluca M. Sampietro, Riccardo Giorgi, Roberto Moretti, Silvano Gallus – 26 April 2007 – The risk for gallstones (GD) in inflammatory bowel diseases and the factors responsible for this complication have not been well established. We studied the incidence of GD in a cohort of Crohn's disease (CD) and ulcerative colitis (UC) patients and investigated the related risk factors. A case‐controlled study was carried out.

Ying Chen, Yi Yang, Marian L. Miller, Dongxiao Shen, Howard G. Shertzer, Keith F. Stringer, Bin Wang, Scott N. Schneider, Daniel W. Nebert, Timothy P. Dalton – 26 April 2007 – Oxidative stress is considered to be a critical mediator in liver injury of various etiologies. Depletion of glutathione (GSH), the major antioxidant in liver, has been associated with numerous liver diseases.

Johan Westin, Kristoffer Hellstrand, Åsa Alsiö, Magdalena Ydreborg, Carlo Ferrari, Avidan U. Neumann, Jean‐Michel Pawlotsky, Solko W. Schalm, Stefan Zeuzem, Elke Verhey‐Hart, Martin Lagging – 26 April 2007

Francesco Vizzutti, Umberto Arena, Roberto G. Romanelli, Luigi Rega, Marco Foschi, Stefano Colagrande, Antonio Petrarca, Stefania Moscarella, Giacomo Belli, Anna Linda Zignego, Fabio Marra, Giacomo Laffi, Massimo Pinzani – 26 April 2007 – Measurement of hepatic venous pressure gradient (HVPG) is a standard method for the assessment of portal pressure and correlates with the occurrence of its complications. Liver stiffness measurement (LSM) has been proposed as a noninvasive technique for the prediction of the complications of cirrhosis.

Gregory T. Everson – 26 April 2007

Geoffrey C. Nguyen, Dorry L. Segev, Paul J. Thuluvath – 26 April 2007 – Having complications of portal hypertension is a harbinger of decompensated cirrhosis and warrants consideration for liver transplantation (LT). Racial disparities in LT have been reported. We sought to characterize disparities in the performing of surgical and endoscopic procedures among hospitalized patients with complications of portal hypertension. We queried the Nationwide Inpatient Sample from 1998 to 2003 to identify patients with cirrhosis and complications of portal hypertension.